Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 120,672
  • Shares Outstanding, K 75,420
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,752 K
  • 60-Month Beta 1.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.38
Trade ONC.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.41
  • Most Recent Earnings $-0.05 on N/A
  • Latest Earnings Date 05/09/24 [AMC]
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.12
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.40 +14.29%
on 04/16/24
1.75 -8.57%
on 04/04/24
+0.11 (+7.38%)
since 04/03/24
3-Month
1.20 +33.33%
on 02/07/24
1.75 -8.57%
on 04/04/24
+0.04 (+2.56%)
since 02/02/24
52-Week
1.20 +33.33%
on 02/07/24
4.49 -64.37%
on 06/23/23
-0.60 (-27.27%)
since 05/03/23

Most Recent Stories

More News
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 1.1700 (unch)
CELC : 17.67 (+0.06%)
OLMA : 10.67 (+5.96%)
BIO : 279.83 (+0.19%)
AZN : 76.35 (+0.73%)
ONC.TO : 1.60 (+0.63%)
Biotech's Developments in Race Against Rising Cancer Rates Revealed

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
CELC : 17.67 (+0.06%)
OLMA : 10.67 (+5.96%)
BIO : 279.83 (+0.19%)
AZN : 76.35 (+0.73%)
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 1.1700 (unch)
ICCM : 1.1900 (+0.85%)
ATOS : 1.6600 (+9.21%)
ARVN : 32.82 (+1.20%)
PFE : 27.81 (+0.40%)
ONC.TO : 1.60 (+0.63%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
ICCM : 1.1900 (+0.85%)
ATOS : 1.6600 (+9.21%)
ARVN : 32.82 (+1.20%)
PFE : 27.81 (+0.40%)
Stocks in play: Oncolytics Biotech Inc

Announced that it will host a conference call and webcast on Thursday, May 9, at 4:30 p.m. ET to discuss ...

ONC.TO : 1.60 (+0.63%)
Stocks in play: Oncolytics Biotech Inc

Today announced that it will host a conference call and webcast on Thursday, May 9, 2024, at 4:30 p.m. ...

ONC.TO : 1.60 (+0.63%)
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)
Stocks in play: Oncolytics Biotech® Inc.

Announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual ...

ONC.TO : 1.60 (+0.63%)
Stocks in play: Oncolytics Biotech Inc

Today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) ...

ONC.TO : 1.60 (+0.63%)
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the...

ONCY : 1.1700 (unch)
ONC.TO : 1.60 (+0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the...

See More

Key Turning Points

3rd Resistance Point 1.65
2nd Resistance Point 1.64
1st Resistance Point 1.62
Last Price 1.60
1st Support Level 1.59
2nd Support Level 1.58
3rd Support Level 1.56

See More

52-Week High 4.49
Fibonacci 61.8% 3.23
Fibonacci 50% 2.84
Fibonacci 38.2% 2.46
Last Price 1.60
52-Week Low 1.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar